GlaxoSmithKline (GSK) EPS & PE Ratio History
Current and historical earning per share (EPS) and price to earnings (PE) ratio for GlaxoSmithKline (GSK) over the last 10 years. The current PE ratio for GlaxoSmithKline as of August 21, 2017 is 13.84.
|Medical||Large Cap Pharmaceutical||$95.296B||$37.820B|
|GlaxoSmithKline is one of the world's leading research based pharmaceutical and healthcare companies and is committed to improving the quality of human life by enabling people to do more, feel better and live longer. They also have leadership in four major therapeutic areas: anti-infectives, central nervous system (CNS), respiratory and gastro-intestinal/metabolic.|